These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16882600

  • 1. Successful treatment of Sjogren's syndrome with rituximab.
    Touma Z, Sayad J, Arayssi T.
    Scand J Rheumatol; 2006; 35(4):323-5. PubMed ID: 16882600
    [No Abstract] [Full Text] [Related]

  • 2. Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al.
    Fresko I, Seyahi E, Yurdakul S.
    Arthritis Rheum; 2004 Dec; 50(12):4077; author reply 4077-8. PubMed ID: 15593208
    [No Abstract] [Full Text] [Related]

  • 3. Will targeting B cells be the answer for Sjögren's syndrome?
    Looney RJ.
    Arthritis Rheum; 2007 May; 56(5):1371-7. PubMed ID: 17469093
    [No Abstract] [Full Text] [Related]

  • 4. Aquaporins in primary Sjögren's syndrome: comment on the articles by Steinfeld et al.
    Waterman SA, Beroukas D, Hiscock J, Jonsson R, Gordon TP.
    Arthritis Rheum; 2003 Apr; 48(4):1167-8. PubMed ID: 12687572
    [No Abstract] [Full Text] [Related]

  • 5. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
    Ahmadi-Simab K, Lamprecht P, Nölle B, Ai M, Gross WL.
    Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765
    [No Abstract] [Full Text] [Related]

  • 6. Rituximab therapy in primary Sjögren's syndrome.
    Alcântara C, Gomes MJ, Ferreira C.
    Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
    [Abstract] [Full Text] [Related]

  • 7. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L, Nedorost S, Mirmirani P.
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract] [Full Text] [Related]

  • 8. Maintenance of rituximab treatment in a patient with primary Sjögren's syndrome.
    Lehner GF, Brunner-Palka M, Rettenbacher T, Schmidauer R, Herold M.
    Rheumatology (Oxford); 2014 Jul; 53(7):1349-50. PubMed ID: 24446469
    [No Abstract] [Full Text] [Related]

  • 9. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, Hutin P, Renaudineau Y, Dueymes M, Loisel S, Berthou C, Saraux A, Youinou P.
    Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
    [Abstract] [Full Text] [Related]

  • 10. Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome.
    Steinfeld SD, Appelboom T, Delporte C.
    Arthritis Rheum; 2002 Aug; 46(8):2249-51. PubMed ID: 12209534
    [No Abstract] [Full Text] [Related]

  • 11. Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma.
    Somer BG, Tsai DE, Downs L, Weinstein B, Schuster SJ, American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines.
    Arthritis Rheum; 2003 Jun 15; 49(3):394-8. PubMed ID: 12794796
    [No Abstract] [Full Text] [Related]

  • 12. First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.
    Nikiphorou E, Hall FC.
    Rheumatology (Oxford); 2014 Oct 15; 53(10):1906-7. PubMed ID: 24729401
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-CD20 treatment in primary Sjögren's syndrome.
    Isaksen K, Jonsson R, Omdal R.
    Scand J Immunol; 2008 Dec 15; 68(6):554-64. PubMed ID: 19000095
    [Abstract] [Full Text] [Related]

  • 15. Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment.
    Meijer JM, Pijpe J, Vissink A, Kallenberg CG, Bootsma H.
    Ann Rheum Dis; 2009 Feb 15; 68(2):284-5. PubMed ID: 19139205
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Successful treatment of a patient with primary Sjögren's syndrome with Rituximab.
    Ring T, Kallenbach M, Praetorius J, Nielsen S, Melgaard B.
    Clin Rheumatol; 2006 Nov 15; 25(6):891-4. PubMed ID: 16283417
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.
    Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X, Club Rhumatismes et Inflammations and the French Society of Rheumatology.
    Ann Rheum Dis; 2013 Jun 15; 72(6):1026-31. PubMed ID: 23264337
    [Abstract] [Full Text] [Related]

  • 20. [Efficiency of rituximab in an unusual form of primary Sjögren's syndrome: a case report].
    Mrabet D, Meddeb N, Sahli H, Saadi F, Chéour E, Elleuch M, Sellami S.
    Therapie; 2010 Jun 15; 65(6):581-3. PubMed ID: 23189757
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.